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Aim: Determine if the association of HIF3A DNA methylation with weight and adiposity 
is detectable early in life. Material & methods: We determined HIF3A genotype and 
DNA methylation patterns (on hybridization arrays) in DNA extracted from umbilical 
cords of 991 infants. Methylation levels at three CpGs in the HIF3A first intron were 
related to neonatal and infant anthropometry and to genotype at nearby polymorphic 
sites. Results & conclusion: Higher methylation levels at three previously described 
HIF3A CpGs were associated with greater infant weight and adiposity. The effect sizes 
were slightly smaller than those reported for adult BMI. There was also an interaction 
within cis-genotype. The association between higher DNA methylation at HIF3A and 
increased adiposity is present in neonates. In this study, no particular prenatal factor 
strongly influenced HIF3A hypermethylation. Our data nonetheless suggest shared 
prenatal influences on HIF3A methylation and adiposity.
Keywords:  birth weight • DNA methylation • embryonic and fetal development  
• epigenomics • HIF3A protein • human • obesity
DNA methylation states at particular loci have 
been associated with a range of disease states 
and environmental exposures. It is desirable 
to know whether particular DNA methyla-
tion changes occur before disease symptoms 
or after as a consequence of the disease, as 
epigenetic biomarkers have been suggested as 
a way of tracking developmental trajectories 
to disease [1].
A large epigenome-wide association study 
(EWAS) with replication in two independent 
cohorts reported that methylation levels at 
three CpGs in the first intron of the hypoxia 
inducible factor 3A (HIF3A) locus were posi-
tively associated with BMI in adult Cauca-
sian whole blood and adipose tissue [2]. The 
finding has since been independently repli-
cated [3]. The authors postulated that HIF3A 
has a role in acquired obesity, perhaps in 
regulating adipocyte differentiation.
There is considerable evidence of develop-
mental pathways to obesity [4–7], beginning 
before birth and at least partly mediated by 
epigenetics [8–10]. Factors acting prenatally 
may affect methylation levels at particular loci, 
which in turn affect transcription and pheno-
type later in life [1]. Birth weight is often used 
as a surrogate for the quality of the in utero 
environment and both low and high birth 
weights are associated with an increased risk 
of obesity and metabolic syndrome [11,12]. An 
association of birth weight or neonatal adipos-
ity with HIF3A methylation at birth would be 
compatible with the developmental origins of 
obesity hypothesis. The effects of the prena-
tal environment on the epigenome could be 
genotype dependent [13] as we have previously 
found that umbilical cord methylation levels 
can associate with various in utero environ-
mental factors in interaction with infant gen-
otype [14]. HIF3A methylation was shown to 
associate with cis-genotype but the genotype 
was not associated with adult BMI [2].
The present study has three objectives. 
First, we tested if HIF3A gene methylation 
levels in umbilical cords were associated with 
birth size (weight and length) and adiposity. 
Second, due to the strong association between 
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cis-SNPs and methylation within the HIF3A locus, we 
studied if the association of methylation with birth 
weight is independent of cis-genotype. Third, we sought 
to identify prenatal environmental variables associated 
with both birth weight and HIF3A methylation.
Materials & methods
Study population
Mother–offspring pairs in our study were drawn from 
the Growing Up in Singapore towards Healthy Out-
comes (GUSTO) birth cohort [15]. Women aged at 
Table 1. Characteristics of participants in the GUSTO cohort studied in the analysis.
 Characteristic Time point n (%) Mean (standard deviation)
Ethnicity: Delivery  
Chinese 568 (57)
Malay  251(25)  
Indian  172 (17)  
Child sex:   
Male 530 (53)
Female  461 (47)  
Gestational age (weeks)   38.9 (1.0)
Weight (g) Delivery 961 3150 (376)
 6 months 872 7744 (919)
 12 months 848 9405 (1073)
 18 months 808 10,770 (1304)
 24 months 820 11,996 (1542)
Length (cm) Delivery 961 49 (2)
 6 months 876 67 (3)
 12 months 850 75 (3)
 18 months 695 82 (3)
 24 months 720 88 (4)
BMI (g/cm2) Delivery 961 1.3 (0.1)
 6 months 872 1.7 (0.2)
 12 months 847 1.6 (0.1)
 18 months 693 1.6 (0.1)
 24 months 720 1.6 (0.1)
Subscapular skinfold (mm) Delivery 962 5.0 (1.2)
 18 months 673 6.4 (1.4)
 24 months 760 6.4 (1.6)
Triceps skinfold (mm) Delivery 963 5.5 (1.2)
 18 months 714 8.6 (1.7)
 24 months 734 8.8 (1.8)
Subscapular: triceps Delivery 962 0.93 (0.17)
 18 months 648 0.76 (0.14)
 24 months 723 0.73 (0.14)
Methylation of cg27146050 Delivery 991 15% (4%)
Methylation of cg16672562   19% (5%)
Methylation of cg22891070   31% (6%)
rs8102595 minor allele frequency (G)   0.22
rs3826795 minor allele frequency (T)   0.41
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least 18 years were prospectively recruited from the 
KK Women’s and Children’s Hospital (KKH) and 
the National University Hospital (NUH) in Singapore 
during their first trimester of pregnancy. Written 
informed consent was obtained. The GUSTO study 
was approved by the ethics boards of both KKH and 
NUH. To be eligible, women had to hold Singapore 
citizenship or permanent residency, intended to reside 
in Singapore for the next 5 years, were of Chinese, 
Malay or Indian ethnicity, had homogeneous parental 
ethnic background and had the intention of delivering 
at either NUH or KKH. Women who were on che-
motherapy, psychotropic drugs or had diabetes mel-
litus were ineligible. Interviewer-administered ques-
tionnaires were used to obtain demographic, medical 
and obstetric data to assess eligibility. Multiple preg-
nancies, preterm and intrauterine growth restriction 
births were excluded from this analysis. There were 
1052 live singleton births after excluding 124 pre-
term and intrauterine growth restriction births. This 
analysis used 991 offspring with complete informa-
tion available on HIF3A methylation at three sites 
(cg27146050, cg16672562, cg22891070), genotype at 
two cis-SNPs (rs8102595 and rs3826795) and at least 
one anthropometric outcome.
Offspring anthropometry
Offspring weight and recumbent length were measured 
at birth, 6, 12, 18 and 24 months of age. Weight was 
measured using a calibrated infant scale (SECA 334 
Weighing Scale, SECA Corp) and recorded to the near-
est gram. Length was measured using a SECA infant 
mat (SECA 210 Mobile Measuring Mat, SECA Corp) 
and recorded to the nearest 0.1 cm. Measurements were 
taken in duplicates for reliability. BMI was derived as 
weight (g) divided by length2 (cm2) at all time points. 
Subscapular and triceps skinfolds were measured at 
birth, 18 and 24 months and taken in triplicates using 
Holtain skinfold calipers (Holtain Ltd, Crymych, UK) 
on the right side of the body, recorded to the near-
est 0.2 mm. Subscapular to triceps skinfold ratio was 
derived by dividing subscapular skinfold (mm) by 
triceps skinfold (mm).
Prenatal environmental exposures
An interviewer-administered questionnaire was con-
ducted at 26–28 weeks of gestation to obtain informa-
tion on occupational activity during pregnancy, exercise 
during pregnancy, alcohol usage before and during preg-
nancy and smoking patterns before and during preg-
nancy (Supplementary File 1; for supplementary informa-
tion please see online at: www.futuremedicine.com/doi/
full/10.2217/EPI.15.45). Maternal height and weight 
were measured during the same time period. Prepreg-
nancy weight was self-reported during study recruitment 
in the first trimester of pregnancy. Pregnancy weight 
gain was calculated as the difference between prepreg-
nancy and 26–28-week weights. Maternal prepregnancy 
BMI was derived as prepregnancy weight divided by 
height squared. Maternal glucose levels, indicative of 
gestational diabetes, (2 h postglucose and fasting) were 
ascertained at 26–28 weeks using an oral glucose toler-
ance test (OGTT) of 75 g after overnight fasting (8–10 
h). Information on maternal glucose levels (2 h postglu-
cose and fasting) were available for 922 subjects. Using 
the 1999 WHO standard criteria (≥7.8 mmol/l for 2-h 
postglucose and/or ≥7.0 mmol/l for fasting glucose), 162 
out of 922 subjects would be diagnosed as having ges-
Table 2. Association between umbilical cord methylation at three sites in HIF3A and six neonatal anthropometric 
outcomes (weight, length, BMI, subscapular skinfold, triceps skinfold and ratio of subscapular to triceps skinfold) 
at birth. 
 cg27146050 cg16672562 cg22891070 
 Est. 95% CI p-value Est. 95% CI p-value Est. 95% CI p-value
Birth weight (g) 3.61 (0.68–6.63) 0.015 3.34 (1.4–5.32) 0.00068 2.05 (0.32–3.82) 0.020
Birth length (cm) 0.60 (-0.29–1.5) 0.19 0.46 (-0.13–1.05) 0.13 0.35 (-0.18–0.88) 0.20
BMI at birth (g/cm2) 2.38 (0.23–4.58) 0.030 2.4 (0.97–3.84) 0.00096 1.35 (0.07–2.64) 0.039
Subscapular skinfold 
at birth (mm)
-0.77 (-5.97–4.72) 0.78 5.44 (1.76–9.25) 0.0035 3.27 (0–6.64) 0.050
Triceps skinfold at 
birth (mm)
-1.28 (-6.42–4.14) 0.64 0.75 (-2.75–4.38) 0.68 0.25 (-2.90–3.51) 0.88
Subscapular: triceps 
at birth
0.50 (-3.85–5.04) 0.83 4.67 (1.66–7.77) 0.0022 3.02 (0.34–5.78) 0.027
Regression coefficients (Est.) and 95% CI are reported as percentage change in outcome for 10% increase in methylation level. p-values are two-sided and p-values 
less than 0.05 are shown in bold. Analysis was done by linear regression of log-transformed outcome against methylation at each CpG site, adjusting for child sex, 
ethnicity, cell type proportions and interactions between ethnicity and cell type proportions.
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tational diabetes in this group. Maternal plasma micro-
nutrient levels, including vitamin D, vitamin B12, cop-
per, iron, zinc and folate, were tested using serum drawn 
at 26–28 weeks of gestation. Birth order and mode of 
delivery were abstracted from hospitals’ medical records.
Methylation & genotyping data
Bisulfite-converted gDNA from umbilical cords was 
interrogated on Infinium® Human Methylation 450 
Bead Chip arrays [16] as per manufacturer’s instructions 
and as described previously [14]. Data were processed as 
previously described [17]. Briefly, signal extraction was 
performed in GenomeStudio™ Methy lation Module 
and raw values were extracted. Probes with data from 
two beads or fewer for any sample, or with signal detec-
tion p-values (calculated from signal vs background of 
the individual bead intensities) greater than 0.01, for 
any sample, were discarded for all samples. The green 
Figure 1. Association between percentage methylation at cg16672562 and birth weight. (A) Box plot of birth weight (horizontal axis) 
binned into four bins of equal numbers of unique values, against % methylation at cg16672562 (vertical axis). Number of individual 
data points, median and mean % methylation of each bin is displayed in the table below the horizontal axis. (B) Heatmap displaying 
% methylation at cg16672562, maximum, medium and minimum methylation are shown in red, white and blue, respectively. Subjects 
are split by binned (four bins of equal number of unique values) birth weight (horizontal axis) and binned (four bins of equal 
number of unique values, last two bins are combined as there are few observations in the last bin) gestational age (vertical axis). 
The progression from blue to red (low to high methylation) as birth weight increases (left to right) is visible in each gestational age 
bin (top to bottom). (C) Scatter plots of birth weight (horizontal axis) against % methylation at cg16672562 (vertical axis), each 
panel displays data for binned gestational ages (four bins of equal number of unique values, last two bins are combined as there 
are few observations in the last bin), ranges for each bin are displayed in panel headers. (D) Heatmap displaying % methylation 
at cg16672562, maximum, medium and minimum methylation are shown in red, white and blue, respectively. Subjects are split by 
binned (four bins of equal number of unique values) birth weight (horizontal axis) and binned (four bins of equal number of unique 
values) birth length (vertical axis). The progression from blue to red (low to high methylation) as birth weight increases (left to 
right) is visible in each birth length bin (top to bottom). (E) Scatter plots of birth weight (horizontal axis) against % methylation at 
cg16672562 (vertical axis), each panel displays data for binned (four bins of equal number of unique values) birth length, ranges for 
each bin are displayed in panel headers. 
For color images please seen online at: www.futuremedicine.com/doi/full/10.2217/EPI.15.45 
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and red channel signals were normalized and the back-
ground signal from the negative probe control values 
was removed. Probe β-values or % methylation values 
were derived from the data. β-values are the ratio of the 
methylated probe intensity and the overall intensity, 
β-value for an ith interrogated CpG site:
max ( 0) max ( 0) + a
max ( 0)
Yi,unmethy, Yi, methy,
bi
=
+
Yii, methy,
Equation 1
where y
i,methy
 and y
i,unmethy
 are the intensities measured 
by the ith methylated and unmethylated probes, 
respectively, averaged over the replicate beads; a is a 
constant offset, which is by default 100. Therefore, 
β-values range between 0 and 1 with 0 representing no 
methylation and 1 representing 100% methylation. 
β-values were further processed to scale the % meth-
ylation range of the type 2 probes to the type 1 probes 
using the procedure suggested by [18]. All data from 
the sex chromosomes were removed and the remaining 
data were subjected to quantile normalization. As part 
of the experimental design, subjects were randomized 
such that key variables (birth weight, child sex, ethnic-
ity, gestational age) were randomly distributed across 
batch/chip/position. Batch effects were observed 
between different runs in the processed data and 
removed by a commonly used empirical Bayes method 
known as COMBAT [19]. Even though chip/position 
were associated with the three HIF3A methylation sites 
in question (Supplementary Table 1), chip/position 
were not associated with any of the six neonatal out-
comes studied in this report (Supplementary Table 2) 
due to experimental design. As chip/position were 
associated only with the independent variable (meth-
ylation) but not the outcome, this minimizes con-
founding bias due to chip/position.
The same umbilical cord DNA samples were 
genotyped using the Illumina Omniexpress + exome 
arrays. Genotyping was performed by the service pro-
vider, Expression Analysis Inc. Data were processed 
in Genome Studio Genotyping Module™. Genotyp-
ing calls were made by the Gen Call software, which 
incorporates a clustering algorithm (GenTrain) and 
a calling algorithm (Bayesianmodel). Gen Call score 
of each single nucleotide polymorphism (SNP) probe 
and call rate of each sample are generated. Geno-
types with a Gen Call score less than 0.15 were not 
considered.
Accounting for cellular heterogeneity from 
methylation data
Umbilical cord tissue consists of a mixture of cell types 
with differing epigenetic profiles. To control for cel-
lular heterogeneity in our samples, we applied three 
methods: one requiring a reference panel of methyla-
tion levels in discrete cell types [20] and two reference-
free methodologies [21,22]. For the former, we estimated 
the proportion of fibroblasts, B cells and T cells using a 
reference panel’s cell-specific methylation profiles [20]. 
The methylation dataset obtained from EMBL-EBI 
European Genome-Phenome Archive [23] under acces-
sion number EGAD00010000460 was used as our ref-
erence panel [24]. The estimated cell fractions were then 
adjusted as covariates in the regression models. Inter-
estingly, the associations between the estimated cellular 
Table 3. Association of two cis-single nucleotide polymorphisms (rs8102595, rs3826795) with methylation at three 
sites in HIF3A. 
 Model cg27146050 cg16672562 cg22891070 
 Est. 95% CI p-value Est. 95% CI p-value Est. 95% CI p-value
CpG ~ rs8102595 1.2 (0.96–1.5) 5.7E-19 2.9 (2.5–3.3) 1.6E-45 3.2 (2.8–3.7) 5.7E-47
CpG ~ rs3826795 0.64 (0.40–0.87) 1.1E-07 1.6 (1.2–1.9) 3.2E-18 1.5 (1.1–1.9) 3.2E-14
Above are results from six different linear regression models. In each linear regression model, methylation at each CpG site is regressed against each SNP. Regression 
coefficients (Est.) and 95% CI reflect changes in % methylation per copy of the effect allele, adjusting for child sex, ethnicity, cell type proportions and interactions 
between ethnicity and cell type proportions. p-values are two-sided and p-values less than 0.05 are shown in bold. The effect allele of rs8102595 is G and the effect 
allele of rs3826795 is C.
Table 4. Association between two cis-single nucleotide polymorphisms at the HIF3A locus 
(rs8102595, rs3826795) and birth weight.
 Single nucleotide polymorphisms Est. 95% CI p-value
rs8102595 0.39 (-0.89–1.7) 0.55
rs3826795 0.059 (-1.0–1.2) 0.92
Regression coefficients (Est.) and 95% CI are reported as percentage change in birth weight per copy of the effect allele. p-values are 
two-sided. Analysis was done by linear regression of log-transformed birth weight against each SNP (additive genetic model), adjusting for 
ethnicity and child sex. The effect allele of rs8102595 is G and the effect allele of rs3826795 is C.
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proportions and child anthropometry were generally 
ethnic-dependent (Supplementary Tables 3 & 4). There-
fore, interaction terms between cellular proportions 
and ethnicity were included in all regression models. 
As a sensitivity analysis, we also applied two refer-
ence-free methods [21,22] to investigate the association 
between methylation levels at HIF3A and log-trans-
formed child anthropometric measures, adjusting for 
infant sex and ethnicity. Leek et al. [22] estimates sur-
rogate variables which capture cellular heterogeneity, 
the surrogate variables are then adjusted as covariates 
in regression analysis. We note that this sensitivity 
analysis using Leek et al. [22] would also act to adjust 
for residual unknown confounding effects, including 
chip/position effects since the estimated surrogate 
variables can potentially capture both cellular hetero-
geneity and residual batch/chip/position effects [21,25–
27]. The method proposed by Houseman et al. [21] is 
similar to the surrogate variable analysis proposed by 
Leek et al. [22] with an additional biological mixing 
assumption. Houseman et al. [21] correct the cellular 
heterogeneity without explicitly estimating the relative 
cell proportions or returning the surrogate variables.
Statistical analysis
Linear regression models were used to examine the 
association of child anthropometric measures with 
HIF3A methylation β-values, with adjustment for 
child sex, ethnicity, cellular composition and interac-
tions between ethnicity and cellular proportions. Child 
anthropometric measures were log-transformed to sat-
isfy statistical assumptions of normality. Due to the log-
transformation, effect sizes are reported as percentage 
increase in child outcome for 10% increase in meth-
ylation β-values. As a sensitivity analysis, we also report 
results additionally adjusted for gestational age. To 
examine if the association between child anthropometry 
with HIF3A methylation were independent of cis-gen-
otypes, we additionally adjusted for both cis-genotypes. 
To identify prenatal environmental exposures associ-
ated with both birth weight and HIF3A methylation, 
we regressed birth weight on various prenatal exposures, 
and adjusted for child sex and ethnicity. We further 
regressed HIF3A methylation on various prenatal expo-
sures (and their interactions with genotype), adjust-
ing for child sex, ethnicity, cellular composition and 
interactions between ethnicity and cellular proportions.
Table 5. Association between umbilical cord methylation at three sites in HIF3A and six neonatal anthropometric 
outcomes (weight, length, BMI, subscapular skinfold, triceps skinfold and ratio of subscapular to triceps skinfold) at 
birth, adjusting for rs8102595 and rs3826795.
Outcome  cg27146050  cg16672562  cg22891070  
 Est. 95% CI p-value Est. 95% CI p-value Est. 95% CI p-value
Birth weight (g) 3.67 (0.62–6.81) 0.018 3.87 (1.7–6.09) 0.00044 2.28 (0.34–4.26) 0.021
Birth length (cm) 0.63 (-0.3–1.57) 0.18 0.55 (-0.11–1.21) 0.10 0.4 (-0.19–1) 0.18
BMI at birth (g/cm2) 2.37 (0.13–4.67) 0.038 2.74 (1.14–4.36) 0.00075 1.46 (0.03–2.91) 0.046
Subscapular skinfold at 
birth (mm)
-0.62 (-6.05–5.11) 0.83 7.08 (2.92–11.41) 0.00073 4.31 (0.64–8.11) 0.021
Triceps skinfold at birth 
(mm)
-0.06 (-5.46–5.65) 0.98 2.64 (-1.33–6.77) 0.19 1.7 (-1.85–5.39) 0.35
Subscapular: triceps 
at birth
-0.6 (-5.06–4.08) 0.8 4.34 (1–7.79) 0.011 2.57 (-0.4–5.63) 0.091
Analysis without adjusting for rs8102595 and rs3826795 are shown in Table 2, results of both are similar. Regression coefficients (Est.) and 95% CI are reported as 
percentage change in outcome for 10% increase in methylation level. p-values are two-sided and p-values less than 0.05 are shown in bold. Analysis was done by 
linear regression of log-transformed outcome against methylation at each CpG site, adjusting for rs8102595, rs3826795, child sex, ethnicity, cell type proportions 
and interactions between ethnicity and cell type proportions.
Table 6. Two-sided p-values from testing for interaction term between log-transformed birth 
weight and single nucleotide polymorphism (rs8102595, rs3826795), with methylation as outcome, 
adjusting for main effect of log-transformed birth weight, main effect of single nucleotide 
polymorphism, child sex, ethnicity, cell type proportions and interactions between ethnicity and cell 
type proportions.
Model  cg27146050  cg16672562  cg22891070  
 p-value p-value p-value
log(BW)* rs8102595 0.32 0.077 0.30
log(BW)* rs3826795 0.34 0.019 0.033
10.2217/EPI.15.45
Figure 2. Association between % methylation at cg16672562 and birth weight, stratified by rs3826795 genotype. 
(A) Scatter plots of birth weight (horizontal axis) against % methylation at cg16672562 (vertical axis), each panel 
displays data for each genotype. (B) Box plot of rs3826795 genotype (horizontal axis) against % methylation 
at cg16672562 (vertical axis). Number of individual data points, median and mean % methylation of each bin is 
displayed in the table below the horizontal axis.
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Results
HIF3A methylation in umbilical cords was 
positively associated with birth weight 
& adiposity
Table 1 gives the characteristics of the 991 infants 
investigated in the current analysis. Higher umbilical 
cord HIF3A methylation level at all three CpGs was 
associated with greater infant birth weight (Table 2 & 
Figure 1A), after adjusting for infant sex, ethnicity, esti-
mated cellular proportions and interactions between 
ethnicity and cellular proportions [20]. There were also 
significant associations with adiposity at birth measured 
by BMI and, for two of the three CpGs, by subscapular 
skinfold and the ratio of subscapular to triceps skinfold 
(thought to reflect fat deposition on the trunk rather 
than limbs [28]) (Table 2). Similar results were obtained 
at two of the CpGs when we used reference-free meth-
odologies [21,22] to account for cellular heterogene-
ity (Supplementary Tables 5 & 6). Despite the strong 
association between gestational age and birth weight 
in our dataset (r = 0.32; p < 0.0005), the associations 
of HIF3A methylation at all three CpGs with birth 
weight remained significant, after adjusting for ges-
tational age (Supplementary Table 7). The association 
between methylation and birth weight was consistent 
across gestational age categories and was perhaps stron-
gest in neonates with the earliest and latest gestational 
ages (Figure 1B & C & Supplementary Table 8). Similarly, 
despite the strong correlation between birth weight and 
length in the dataset (r = 0.67; p < 0.0005), HIF3A 
methylation was not significantly associated with birth 
length and the association between methylation and 
birth weight was consistent across birth length catego-
ries (Figure 1D & E), suggesting a link between HIF3A 
methylation and adiposity at birth rather than birth size 
in general.
For every 10% increase in methylation of 
cg27146050, cg16672562 and cg22891070, birth 
weight was 3.61% (95% CI: 0.68–6.63), 3.34% 
(1.4–5.32) and 2.05% (0.32–3.82) higher, respectively 
(Table 2). These effect sizes are slightly smaller than the 
corresponding effect estimates on adult BMI of 7.8% 
(5.1–10.4), 3.2% (2.0–4.4) and 3.6% (2.4–4.9), as 
previously reported [2].
The association of HIF3A methylation & birth 
weight remained significant after adjusting 
for cis-acting SNPs; but birth weight & HIF3A 
methylation was more strongly correlated in 
one genotypic group
Using the same 991 GUSTO umbilical cord samples, 
we genotyped the SNPs identified as cis-influencing 
HIF3A methylation in the Dick et al.’s study [2]. We 
found that rs8102595 and rs3826795 were strongly 
associated with methylation levels at all three CpGs 
sites (Table 3). However, neither SNP was associated 
with birth weight (Table 4) and the associations of birth 
weight with methylation at all three sites were similar 
when adjusted for genotype at both SNPs (Table 5). 
This mirrors the findings of [2]. We also tested if HIF3A 
methylation levels were explained by an interaction of 
HIF3A genotype and infant birth weight (adjusting for 
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Figure 3. Three of the simplest possible scenarios to explain the relationship between HIF3A methylation and 
adiposity.
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main effects of both genotype and infant birth weight), 
as we have previously found that neonatal methylation 
patterns are often a product of the interaction of the 
in utero environment and genotype. The interaction 
term was significant at p < 0.05 for two of the CpGs 
and rs3826795 (Table 6). In the CC genotype group, 
birth weight was more strongly correlated with HIF3A 
methylation (Figure 2 & Supplementary Table 9). The 
CC genotype was also associated with higher methyla-
tion values at the HIF3A locus (Table 3 & Figure 2). This 
suggests the CC genotypic group could be more plastic 
to environmental exposures in utero.
The prenatal environmental variables examined 
were not consistently associated with HIF3A 
methylation & birth weight
As we hypothesized that HIF3A methylation and birth 
weight were related to the prenatal environment, we 
examined for significant associations with both HIF3A 
methylation and birth weight for a range of factors 
10.2217/EPI.15.45
Figure 4. Association between umbilical cord methylation at three sites in HIF3A and child weight measured at 0, 6, 12, 18 and 
24 months. (A) Without adjusting for birth weight. (B) Adjusted for log-transformed birth weight. Regression coefficients (Est.) 
and 95% CI are reported as percentage change in child weight for 10% increase in methylation level. P-values are two-sided. Using 
linear regression models estimated using generalized estimating equations to account for repeated measures, we regressed log-
transformed weight against methylation at each CpG site, adjusting for fixed effects of time, child sex, ethnicity, cell type proportions 
and interactions between ethnicity and proportions. Time was coded using a binary variable for each distinct time point and 
interaction terms of time with all variables (methylation, child sex, ethnicity, cell type proportions and interactions between ethnicity 
and proportions) were included.
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related to the prenatal environment, both as main 
effects and in interaction with HIF3A genotype. Factors 
investigated included antenatal lifestyle factors such as 
activity level and smoking, maternal prepregnancy BMI 
and pregnancy weight gain, maternal glucose tolerance 
during pregnancy indicative of gestational diabetes, 
maternal micronutrient levels, maternal age and par-
ity (Supplementary File 1). There were some suggestive 
associations; for example, maternal glucose tolerance 
(indicative of gestational diabetes) was significantly 
associated with both HIF3A methylation at one of the 
CpGs and birth weight. Furthermore, maternal weight 
gain during pregnancy was significantly associated both 
with infant birth weight and HIF3A methylation (again 
at only one CpG) in interaction with genotype. How-
ever, we did not find any prenatal environmental vari-
ables that showed consistently significant association 
with all three HIF3A sites and birth weight and none 
yielded substantial effect sizes.
Discussion
We have extended the finding that HIF3A DNA meth-
ylation in adults associates with BMI [2], to show that 
the link between HIF3A DNA methylation with weight 
and adiposity can be detected at birth. Interestingly, 
the association was limited to measures of adiposity 
(i.e., weight, BMI and skinfolds) and not other deter-
minants of birth size or putative proxies for gestational 
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quality such as gestational age and birth length. As such, 
the relationship of increased methylation at HIF3A 
CpGs with birth outcomes is reminiscent of the effect of 
maternal diseases, like Type 1 diabetes, on the offspring, 
whereby weight is increased, but length is not [29].
Although pertaining to the same three CpGs within the 
HIF3A gene that were previously reported, our data were 
derived from a different tissue (umbilical cord vs blood 
and adipose), in a different population (Asian vs Cauca-
sian), in a population-based cohort (normative range vs 
study population for metabolic disorders and controls) 
and most importantly at a different stage in the life-
course (neonates vs adults). The effect size reported here 
are slightly smaller than those reported by Dick et al. [2]. 
Reasons the effect sizes are smaller could be statistical, 
population dependent (our population are healthy babies, 
Dick et al. studied a disease cohort with a high level of 
obesity) or developmental (the effect is smaller at birth 
and increases during the lifecourse as adiposity increases).
Replicated positive associations such as the one 
described here can guide future hypothesis-free EWAS. 
Lack of statistical power is a big challenge in EWAS, 
especially in cohorts of modest size. The integration of 
effects of cellular heterogeneity, cis and trans genotype 
and the potential influence of pregnancy conditions is 
also challenging. Therefore, a detailed case study of a 
proposed association (HIF3A with adiposity replicated 
across populations and ages) is important. It will help 
set the standards for statistical replication and delineate 
the issues to consider when evaluating hits from more 
open-ended screening.
Dick et al. [2] considered three possibilities that 
could explain the association between HIF3A methyla-
tion and adiposity in adults: (i) a confounding factor 
(e.g., environment) independently affects both HIF3A 
methylation and adiposity, (ii) increased HIF3A meth-
ylation causes increased adiposity and (iii) increased 
adiposity causes increased HIF3A methylation. To put 
our findings in neonates in context with the findings 
in adults, the same three simplified possible scenarios 
are schematically depicted in Figure 3. We note that 
more complicated scenarios or combinations of these 
simplified situations are possible and likely.
Using a Mendelian randomization reasoning [30] 
from the observation that HIF3A genotype was asso-
ciated with HIF3A methylation but not adult BMI, 
Dick et al. [2] suggested that scenario (iii) (adiposity 
results in HIF3A hypermethylation) is more likely than 
scenario (ii) (HIF3A hypermethylation leads to increased 
adiposity). However, in this context, Mendelian random-
ization assumes the genotype can affect the phenotype 
only through DNA methylation and not through other 
biological pathways. The applicability of this assumption 
is unknown for HIF3A genotype. We cannot confer cau-
sality in our dataset but following the same arguments, 
increased DNA methylation at the HIF3A locus could 
result from increased birth weight/adiposity and not 
cause it, but the aforementioned limitation also applies 
in our case.
Dick et al. considered scenario (i) less likely as they did 
not find an association between HIF3A methylation and 
BMI-related characteristics like diabetes. However, the 
absence of an association between HIF3A methylation 
and diabetes could also be due to the same confound-
ing factor having a direct effect on glucose tolerance 
that is independent of increased adiposity. We postulate 
that scenario (i) could involve a prenatal environmen-
tal factor that independently affected both birth weight 
and HIF3A methylation. We also find that, as may be 
expected from other studies [14,31], interindividual varia-
tion in HIF3A methylation can be explained by an inter-
action of genotype and birth weight, suggesting there 
may be a genotype group (CC) particularly sensitive to 
gestational environment (Table 6 & Figure 2). However, 
in this study, we were unable to definitively identify a 
factor acting prenatally that is consistently associated 
with both HIF3A methylation and birth weight, despite 
the extensive dataset on pregnancy environments col-
lected from the GUSTO cohort and examined in this 
study. Nevertheless, HIF3A methylation at birth after 
much further study, may prove to be a useful surrogate 
for likely metabolic trajectory determined by gestational 
environment [32], and could be more useful than birth 
weight as it would be independent of the inherited 
genetic and environmental determinants of birth weight.
Transgenerational transmission of obesity 
and the importance of the very early environ-
ment in determining metabolic trajectories have 
been much studied [33,34]. If metabolic trajectory 
is programmed during gestation, a biomarker of 
likely trajectory would aid intervention [1]. Birth 
weight has been shown to predict later weight [35] 
and is strongly associated with later weight in the 
GUSTO cohort. Interestingly, HIF3A methylation 
levels at birth were also associated with weights 
at later ages, albeit possibly with slightly lower 
effect sizes (Figure 4A & Supplementary  Table 10). 
Only a few of the associations survive at border-
line significance when adjusted for birth weight 
(Figure 4B & Supplementary Table 11), thus the asso-
ciation of HIF3A methylation with later weights 
may reflect the growth trajectory set at birth. The 
‘dip’ in the effect size at 6 months could be due to 
the effects of weaning or the decreased influence 
of genetic factors [36,37], although it is interesting 
to note that birth weight is more correlated with 
weight at 6 months than with weight at any of the 
other time points (Supplementary Tables 12 & 13).
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Future studies should track both HIF3A methylation 
and offspring size and adiposity longitudinally during 
gestation, at birth, and at subsequent ages to determine 
if the association of HIF3A methylation with adiposity 
is consistent. As blood and adipose are invasive tissues 
to sample in infants, HIF3A methylation levels should 
be investigated in other tissue types such as saliva, buc-
cal swabs or circulating fetal cells obtained prenatally. 
Longitudinal studies can help determine, if HIF3A is 
a biomarker for obesity risk and assess the utility of 
using HIF3A methylation to evaluate the efficacy of 
interventions such as lifestyle modification. Future 
studies should also examine the impact of HIF3A meth-
ylation changes on gene expression in relevant tissues. 
Dick et al. [2] found a negative association between 
HIF3A methylation levels and HIF3A gene expression 
in adipose tissue. It is a limitation of our study that we 
cannot examine gene expression in a relevant tissue 
due to the unfeasibility of sampling adipose tissue in 
neonates or infants.
Conclusion
The association between increased DNA methylation 
at HIF3A and increased adiposity is present in neo-
nates. This suggests HIF3A methylation is a potential 
biomarker for metabolic trajectory and/or implicated 
in metabolic syndrome and further study is warranted.
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Executive summary
Introduction
•	 Variation in DNA methylation between individuals is a product of influences from the environment and 
individual genetic backgrounds.  
•	 DNA methylation levels at particular loci may closely map trajectories to diseases such as obesity, which have 
environmental and genetic components.  
•	 A recent study linked methylation within the HIF3A gene to BMI and obesity in adults.  
•	 Individual susceptibility to obesity is influenced by early environmental exposures.  
•	 This study investigates whether the association of HIF3A methylation with adiposity can be detected at birth.
Material & methods
•	 The study was conducted in the 991 subjects from the GUSTO birth cohort.  
•	 We determined HIF3A genotype and DNA methylation patterns in DNA extracted from umbilical cords of the 
991 infants using Illumina Infinium HumanMethylation and Omniexpress arrays.  
•	 Associations of methylation levels and birth outcomes were adjusted for sex, ethnicity, cellular composition of 
umbilical cords and interactions between ethnicity and cellular composition.
Results
•	 Higher DNA methylation within HIF3A measured in umbilical cord tissue was associated with greater infant 
birth weight and adiposity.  
•	 The association of HIF3A methylation and birth weight remained significant after adjusting for cis-acting 
single nucleotide polymorphisms; but the association was stronger in one genotypic group.  
•	 None of the prenatal environmental variables examined were consistently associated with HIF3A methylation 
and birth weight.
Discussion
•	 We have extended the previous finding that HIF3A DNA methylation in adults associates with BMI to show 
that the link between HIF3A DNA methylation with weight and adiposity can be detected at birth.  
•	 Although pertaining to the same three CpGs within the HIF3A gene that were previously reported, our data 
were derived from a different tissue (umbilical cord vs blood and adipose), in a different population (Asian vs 
Caucasian), in a population-based cohort (normative range vs study population for metabolic disorders and 
controls) and most importantly at a different stage in the lifecourse (neonates vs adults).  
•	 This suggests that prenatal factors may influence HIF3A methylation but despite the extensive data collected 
in the GUSTO, we were unable to definitively identify a responsible prenatal factor.  
•	 We were unable to imply causality in our data and do not know whether adiposity causes HIF3A 
hypermethylation, HIF3A hypermethylation causes adiposity or if some independent factor influences both.  
•	 In their study of HIF3A methylation and adult BMI, Dick et al. used Mendelian randomization to suggest that 
HIF3A hypermethylation is a consequence of increased adiposity. We could draw the same conclusion from our 
data but note that some of the assumptions of Mendelian randomization might not be satisfied.  
•	 We suggest that as the association between HIF3A methylation and adiposity is detectable so early in life, 
HIF3A may be a potential biomarker of metabolic trajectory.
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